Related Experiment Videos
Psychogenic excoriation responding to fluoxetine: a case report
1Department of Psychiatry, PS Medical College and SK Hospital, Karamsad 388325.
Journal of the Indian Medical Association
|October 3, 2008
Summary
Psychogenic excoriation, a compulsive skin picking disorder, affects 2% of dermatology patients. Treatment with fluoxetine and behavior therapy led to full recovery in a case study.
Area of Science:
- Psychodermatology
- Behavioral science
Background:
- Psychogenic excoriation (also known as neurotic excoriation or dermatotillomania) is a condition involving compulsive skin picking.
- It affects approximately 2% of dermatology patients, predominantly women, and can manifest with or without underlying skin pathology or itch.
Observation:
- A case of a young female patient presenting with multiple excoriated lesions on the face, arms, and forearms was observed.
- The lesions resulted from self-inflicted manipulation using various objects.
Findings:
- The diagnosis was confirmed as psychogenic excoriation, an uncommon psychodermatological condition.
- The patient received treatment combining fluoxetine (a selective serotonin reuptake inhibitor) and behavior therapy (habit reversal training).
Implications:
- This case highlights the effectiveness of pharmacotherapy and behavioral interventions in managing psychogenic excoriation.
- Early diagnosis and integrated treatment approaches are crucial for successful patient outcomes in psychodermatological conditions.
Related Concept Videos
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
Anxiety: Overview
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...